Circulating Tumor DNA Monitoring in Breast Cancer Undergoing Neoadjuvant Therapy
Status: RECRUITING
Study type: OBSERVATIONAL
Conditions: Stage I-III Breast Cancer
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Collaborators: GeneCast Biotechnology Co., Ltd.